KRT5 and neoplasm: When these lineage specifiers are lost in normal SPC-positive cells (concomitant with KRASG12D activation), the resulting neoplasia equilibrates to a uniform SCJ-like state marked by a CK7-positive/CK5-negative immunophenotype.